Abstract
Polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) are two classes of structurally and toxicologically similar persistent environmental contaminants. These compounds are formed as by-products in various chemical and combustion processes and are now global environmental contaminants. The environmental persistence and lipophilic properties of these compounds have led to effective transport of these chemicals into the food chain with pronounced accumulation at higher trophic levels, including humans. As a result, there is concern regarding possible adverse effects of these contaminants on human health and the environment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R. A. Neal, J. R. Olson, T. A. Gasiewicz, and L. E. Geiger, The toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mammalian systems, Drug Metab. Rev. 13(3), 355–385 (1982).
T. A. Gasiewicz, J. R. Olson, L. E. Geiger, and R. A. Neal, Absorption, distribution and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in experimental animals, in: Human and Environmental Risks of Chlorinated Dioxins and Related Compounds (R. E. Tucker, A. L. Young, and A. P. Gray, eds.), pp. 495–525, Plenum Press, New York (1983).
J. R. Olson, T. A. Gasiewicz, L. E. Geiger, and R. A. Neal, The metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mammalian systems, in: Accidental Exposure to Dioxins: Human Health Aspects (R. Coulston and F. Pocchiari, eds.), pp. 81–100, Academic Press, New York (1983).
L. S. Birnbaum, The role of structure in the disposition of halogenated aromatic xenobiotics, Environ. Health Perspect. 61, 11–20 (1985).
M. Van den Berg, J. deJongh, H. Poiger, and J. R. Olson, The toxicokinetics and metabolism of PCDDs and PCDFs and their relevance for toxicity, CRC Crit. Rev. Toxicol. 24(1), 1–74 (1994).
H. Beck, K. Eckart, W. Mathar, and R. Wittkowski, PCDD and PCDF body burden from food intake in the Federal Republic of Germany, Chemosphere 18, 417–424 (1989).
P. Furst, C. Furst, and K. Wilmers, Body burden with PCDD and PCDF from food, in: Biological Basis for Risk Assessment of Dioxins and Related Compounds (M. A. Gallo, R. J. Scheuplein, and K. A. van der Heijden, eds.), pp. 133–142, Banbury Report 35, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1991).
J. Q. Rose, J. C. Ramsey, T. H. Wentzler, R. A. Hummel, and P. J. Gehring, The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the rat Toxicol Appl. Pharmacol. 36, 209–226 (1976).
W. N. Piper, J. Q. Rose, and P. J. Gehring, Excretion and tissue distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat, Environ. Health Perspect. 5, 241–244 (1973).
J. R. Olson, T. A. Gasiewicz, and R. A. Neal, Tissue distribution, excretion, and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the golden Syrian hamster, Toxicol. Appl. Pharmacol. 56(1), 78–85 (1980).
H. Poiger and C. Schlatter, Pharmacokinetics of 2,3,7,8-TCDD in man, Chemosphere 15(9), 1489–1494 (1986).
J. J. Diliberto, L. B. Kedderis, and L. S. Birnbaum, Absorption of 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in male rats, Toxicologist 10, 54 (1990).
L. S. Birnbaum, G. M. Decad, and H. B. Matthews, Disposition and excretion of 2,3,7,8-tetrachlorodibenzofuran in the rat, Toxicol. Appl. Pharmacol. 55, 342–352 (1980).
G. M. Decad, L. S. Birnbaum, and H. B. Matthews, 2,3,7,8-Tetrachlorodibenzofuran tissue distribution and excretion in guinea pigs, Toxicol. Appl. Pharmacol. 57, 231–240 (1981).
Y. M. Ioannou, L. S. Birnbaum, and H. B. Matthews, Toxicity and distribution of 2,3,7,8-tetrachlorodibenzofuran in male guinea pigs, J. Toxicol, Environ, Health 12, 541–553 (1983).
D. W. Brewster and L. S. Birnbaum, Disposition and excretion of 2,3,7,8-pentachlorodibenzofuran in the rat, Toxicol. Appl. Pharmacol. 90, 243–252 (1987).
R. H. Wacker, H. Poiger, and C. Schlatter, Pharmacokinetics and metabolism of 1,2,3,7,8-pentachlorodibenzo-p-dioxin in the rat, Chemosphere 15(9–12), 1473–1476 (1986).
L. S. Birnbaum and L. A. Couture, Disposition of octachlorodibenzo-p-dioxin (OCDD) in male rats, Toxicol. Appl. Pharmacol. 93, 22–30 (1988).
H. Poiger and C. H. Schlatter, Influence of solvents and absorbants on dermal and intestinal absorption of TCDD, Food Cosmet. Toxicol. 18, 477–481 (1980).
E. E. McConnell, G. W. Lucier, R. C. Rumbaugh, et al., Dioxin in soil; Bioavailability after ingestion by rats and guinea pigs, Science 223, 1077–1079 (1984).
G. W. Lucier, R. C. Rumbaugh, Z. McCoy, R. Hass, D. Harvan, and P. Albro, Ingestion of soil contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters hepatic enzyme activities in rats, Fundam. Appl. Toxicol. 6, 364–371 (1986).
H. Shu, D. Paustenbach, F. J. Murray, et al. Bioavailability of soil-bound TCDD: Oral bioavailability in the rat, Fundam. Appl. Toxicol. 10, 648–654 (1988).
T. H. Umbreit, E. J. Hesse, and M. A. Gallo, Bioavailability of dioxin in soil from a 2,4,5-T manufacturing site, Science 232, 497–499 (1986).
T. H. Umbreit, E. J. Hesse, and M. A. Gallo, Comparative toxicity of TCDD contaminated soil from Times Beach, Missouri and Newark, New Jersey, Chemosphere 15(9–12), 2121–2124 (1986).
D. W. Brewster, Y. B. Banks, A. M. Clark, and L. S. Birnbaum, Comparative dermal absorption of 2,3,7,8-tetrachlorodibenzo-p-dioxin and three polychlorinated di-benzofurans, Toxicol. Appl. Pharmacol. 97, 156–166 (1989).
Y. B. Banks and L. S. Birnbaum, Absorption of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) after low dose dermal exposure, Toxicol. Appl. Pharmacol. 107, 302–310 (1991).
M. S. Rahman, J. L. Zatz, T. H. Umbreit, and M. A. Gallo, Comparative in vitro permeation of 2,3,7,8-TCDD through hairless mouse and human skin, Toxicologist 12, 80 (1992).
M. A. Gallo, M. S. Rahman, J. L. Zatz, and R. J. Meeker, In vitro dermal uptake of 2,3,7,8-TCDD in hairless mouse and human skin from laboratory-contaminated soils, Toxicologist 12, 80 (1992).
L. W. D. Weber, A. Zesch, and K. Rozman, Penetration, distribution and kinetics of 2,3,7,8-TCDD in human skin in vitro, Arch. Toxicol. 65, 421–428 (1991).
H. Shu, D. P. Teitelbaum, A. S. Webb, et al., Bioavailability of soil-bound TCDD: Dermal bioavailability in the rat, Fundam. Appl. Toxicol. 10, 335–343 (1988).
C. S. Nessel, M. A. Amoruso, T. H. Umbreit, and M. A. Gallo, Hepatic aryl hydrocarbon hydroxylase and cytochrome P450 induction following the transpulmonary adsorption of TCDD from intratracheally instilled particles, Fundam. Appl. Toxicol. 15, 500–509 (1990).
C. S. Nessel, M. A. Amoruso, T. H. Umbreit, R. J. Meeker, and M. A. Gallo, Pulmonary bioavailability and fine particle enrichment of 2,3,7,8-TCDD in respirable soil particles, Fundam. Appl. Toxicol. 19, 279–285 (1992).
M. R. Lakshmanan, B. S. Campbell, S. J. Chirtel, N. Ekarohita, and M. Ezekiel, Studies on the mechanism of absorption and distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat, J. Pharmacol. Exp. Ther. 239(3), 673–677 (1986).
D. G. Patterson, P. Furst, L. O. Henderson, D. G. Issacs, L. R. Alexander, W. E. Turner, L. L. Needham, and H. Hannon, Partitioning of in vivo bound PCDD/PCDFs among various compartments in whole blood, Chemosphere 19, 135 (1989).
L. O. Henderson and D. G. Patterson, Jr., Distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human whole blood and its association with, and extractability from lipoproteins, Bull. Environ. Contam. Toxicol. 40, 604–611 (1988).
J. D. McKinney, K. Chae, S. J. Oatley, and C. C. F. Blake, Molecular interactions of toxic chlorinated dibenzo-p-dioxins and dibenzofurans with thyroxine binding pre-albumin, J. Med. Chem. 28, 375–381 (1985).
L. G. Pedersen, T. A. Darden, S. J. Oatley, and J. D. McKinney, A theoretical study of the binding of polychlorinated biphenyls (PCBs) dibenzodioxins and dibenzofuran to human plasma prealbumin, J. Med. Chem. 29, 2451–2457 (1986).
M. Marinovich, C. R. Sirtori, C. L. Galli, and R. Paoletti, The binding of 2,3,7,8-tetrachlorodibenzodioxin to plasma lipoproteins may delay toxicity in experimental hyperlipidemia, Chem. Biol. Interact, 45, 393–399 (1983).
R. B. Shireman and C. Wei, Uptake of 2,3,7,8-tetrachlorodibenzo-p-dioxin from plasma lipoproteins by cultured human fibroblasts, Chem. Biol. Interact. 58, 1–12 (1986).
R. Weisiger, J. Gollan, and R. Ockner, Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances, Science 211, 1048–1050 (1981).
R. Pohjanvirta, T. Vartiainen, A. Usi-Rauva, J. Monkkonen, and T. Tuomisto, Tissue distribution, metabolism, and excretion of [14C]-TCDD in a TCDD-susceptible and TCDD-resistant rat strain, Pharmacol. Toxicol. 66, 93–100 (1990).
D. W. Brewster and L. S. Birnbaum, Disposition of 1,2,3,7,8-pentachlorodibenzofuran in the rat, Toxicol. Appl. Pharmacol. 95, 490–498 (1988).
D. Neubert, T. Wiesmuller, K. Abraham, R. Krowke, and H. Hagenmaier, Persistence of various polychlorinated dibenzo-p-dioxin and dibenzofurans (PCDDs and PCDFs) in hepatic and adipose tissue of marmoset monkeys, Arch. Toxicol. 64, 431–442 (1990).
K. Abraham, T. Wiesmuller, H. Brunner, R. Krowke, H. Hagenmaier, and D. Neubert, Absorption and tissue distribution of various polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs and PCDFs) in the rat, Arch. Toxicol. 63, 193–202 (1989).
A. Facchetti, A. Fornari, and M. Montagna, Distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the tissues of a person exposed to the toxic cloud at Seveso (Italy), Adv. Mass Spectrom. 8B, 1405–1414 (1980).
H. J. Geyer, I. Scheunert, J. G. Filser, and F. Korte, Bioconcentration potential (BCP) of 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) in terrestrial organisms including humans, Chemosphere 15(9–12), 1495–1502 (1986).
D. G. Patterson, Jr., L. Hampton, C. R. LaPeza, Jr., et al., High resolution gas chromatographic/high resolution mass spectrometric analysis of human serum on a whole-weight and lipid basis for 2,3,7,8-tetrachlorodibenzo-p-dioxin, Anal. Chem. 59, 2000–2005 (1987).
D. G. Patterson, Jr., L. L. Needham, J. L. Pirkle, et al., Correlation between serum and adipose tissue levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in 50 persons from Missouri, Arch. Environ. Contam. Toxicol. 17, 139–143 (1988).
P. C. Kahn, M. Gochfeld, M. Nygren, et al., Dioxins and dibenzofurans in blood and adipose tissue of Agent Orange-exposed Vietnam veterans and matched controls, J. Am. Med. Assoc. 259(11), 1661–1667 (1988).
A. Schecter, J. J. Ryan, J. D. Constable, R. Baughman, J. Bangert, P. Furst, K. Wilmers, and R. D. Oates, Partitioning of 2,3,7,8-chlorinated dibenzo-p-dioxins and dibenzofurans between adipose tissue and plasma lipid of 20 Massachusetts Vietnam veterans, Chemosphere 20, 951 (1990).
A. Schecter, Dioxins and related chemicals in humans and the environment, in: Biological Basis for Risk Assessment of Dioxins and Related Compounds (M. A. Gallo, R. J. Scheuplein, and K. A. van der Heijnen, eds.), pp. 169–212, Banbury Report 35, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1991).
H. Thoma, W. Mucke, and E. Kretschmer, Concentrations of PCDD and PCDF in human fat and liver samples, Chemosphere 18(1–6), 491–498 (1989).
H. Thoma, W. Mucke, and G. Kauert, Comparison of the polychlorinated dibenzo-p-dioxin and dibenzofuran in human tissue and human liver, Chemosphere 20, 433–442 (1990).
A. J. Schecter, J. J. Ryan, M. Gross, N. C. A. Weerasinghe, and J. Constable, Chlorinated dioxins and dibenzofurans in human tissues from Vietnam, 1983–1984, in: Chlorinated Dioxins and Dibenzofurans in Perspective (C. Rappe, G. Choudhary, and L. H. Keith, eds.), pp. 3–16, Lewis Publishers, Chelsea, MI (1986).
A. Schecter, J. Mes, and D. Davies, Polychlorinated biphenyl (PCB), DDT, DDE and hexachlorobenzene (HCB) and PCDD/F isomer levels in various organs in autopsy tissue from North American patients, Chemosphere 18, 811–818 (1989).
Centers for Disease Control, Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin levels in Air Force health study participants—Preliminary report, Morbidity and Mortality Weekly Report 3(20), 309–311 (1988).
A. Schecter, J. D. Constable, J. V. Bangert, H. Tong, S. Arghestani, S. Monson, and M. Gross, Elevated body burdens of 2,3,7,8-tetrachlorodibenzodioxin in adipose tissue of United States Vietnam veterans, Chemosphere 18, 431 (1989).
K. Abraham, R. Krowke, and D. Neubert, Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection, Arch. Toxicol. 62, 359–368 (1988).
L. S. Birnbaum, Distribution and excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin in congenic strains of mice which differ at the Ah locus, Drug Metab. Dispos. 14(1), 34–40 (1986).
R. E. Bowman, S. L. Schantz, N. C. A. Weerasinghe, M. L. Gross, and D. A. Barsotti, Chronic dietary intake of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at 5 or 25 parts per trillion in the monkey: TCDD kinetics and dose-effect estimate of reproductive toxicity, Chemosphere 18(1–6), 243–252 (1989).
NATO/CCMS (North Atlantic Treaty Organization, Committee on the Challenges of Modern Society), International Toxicity Equivalency Factor (I-TEF) Method of Risk Assessment for Complex Mixtures of Dioxins and Related Compounds, Report No. 176 (1988).
U.S. EPA, Interim Procedures for Estimating Risks Associated with Exposures to Mixtures of Chlorinated Dibenzo-p-dioxins and Dibenzofurans (CDDs and CDFs) and 1989 Update, Risk Assessment Forum, Washington, DC (1989).
A. Schecter, T. Tiernan, F. Schaffner, et al., Patient fat biopsies for chemical analysis and liver biopsies for ultrastructural characterization after exposure to polychlorinated dioxins, furans and PCBs, Environ. Health Perspect. 60, 241–254 (1985).
A. J. Schecter, J. J. Ryan, and J. D. Constable, Chlorinated dibenzo-p-dioxin and di-benzofuran levels in human adipose tissue and milk samples from the north and south of Vietnam, Chemosphere 15, 1613–1620 (1986).
J. J. Ryan, Variation of dioxins and furans in human tissues, Chemosphere 15, 1585–1593 (1986).
C. Rappe, M. Nygren, G. Linstrom, and M. Hansson, Dioxins and dibenzofurans in biological samples of European origin, Chemosphere 15, 1635–1639 (1986).
H. Beck, K. Eckart, W. Mathar, and R. Wittkowski, Isomerenspeczifische Bestimmung von PCDD und PCDF in Human-und Lebensmittelproben, VDI Ber. 634, 359–382 (1987).
H. Poiger, N. Pluess, and C. Schlatter, Subchronic toxicity of some chlorinated dibenzofurans in rats, Chemosphere 18(1–6), 265–275 (1989).
L. B. Kedderis, J. J. Diliberto, P. Linko, J. A. Goldstein, and L. S. Birnbaum, Disposition of TBDD and TCDD in the rat: Biliary excretion and induction of cytochromes P450IA1 and P450IA2, Toxicol. Appl. Pharmacol. 111, 163–172 (1991).
L. R. Curtis, N. I. Kerkvliet, L. Baecher-Steppan, and H. M. Carpenter, 2,3,7,8-Tetrachlorodibenzo-p-dioxin pretreatment of female mice altered tissue distribution but not hepatic metabolism of a subsequent dose, Fundam. Appl. Toxicol. 14, 523–531 (1990).
A. Poland, P. Teitelbaum, E. Glover, and A. Kende, Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonists for the Ah receptor, Mol. Pharmacol. 36, 121–127 (1989).
H.-W. Leung, A. Poland, D. J. Paustenbach, F. J. Murray, and M. E. Andersen, Pharmacokinetics of [125I]-2-iodo-3,7,8-trichlorodibenzo-p-dioxin in mice: Analysis with a physiological modeling approach, Toxicol. Appl. Pharmacol. 103, 411–419 (1990).
E. S. Shen and J. R. Olson, Relationship between the murine Ah phenotype and the hepatic uptake and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin, Drug Metab. Dispos. 15(5), 653–660 (1987).
R. J. Kociba, D. G. Keyes, J. E. Beyer, et al., Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats, Toxicol. Appl. Pharmacol. 46(2), 279–303 (1978).
R. J. Kociba, D. G. Keyes, J. E. Beyer, and R. M. Carreon, Toxicologic studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats, Toxicol. Occup. Med. 4, 281–287 (1978).
R. J. Kociba, P. A. Keeler, C. N. Park, and P. J. Gehring, 2,3,7,8-Tetrachlorodibenzo-p-dioxin results of a 13-week oral toxicity study in rats, Toxicol. Appl. Pharmacol. 35, 553–574 (1976).
A. M. Tritscher, J. A. Goldstein, C. J. Portier, Z. McCoy, G. C. Clark, and G. W. Lucier, Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: Quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver, Cancer Res. 52, 3436–3442 (1992).
H.-W. Leung, J. M. Wendling, R. Orth, F. Hileman, and D. J. Paustenbach, Relative distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatic and adipose tissues, Toxicol. Lett. 50, 275–282 (1990).
R. Voorman and S. D. Aust, Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P-450d to the cytochrome and inhibition of its estradiol 2-hydroxylase activity, Toxicol. Appl. Pharmacol. 90, 69–78 (1987).
R. Voorman and S. D. Aust, TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) is a tight binding inhibitor of cytochrome P-450d, J. Biochem. Toxicol. 4, 105–109 (1989).
A. P. Poland, E. Teitelbaum, and E. Glover, [125I]-iodo-3,7,8-trichlorodibenzo-p-dioxin binding species in mouse liver induced by agonists for the Ah receptor: Characterization and identification, Mol. Pharmacol. 36, 113–120 (1989).
J. C. Ramsey, J. G. Hefner, R. J. Karbowski, W. H. Braun, and P. J. Gehring, The in vivo biotransformation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the rat, Toxicol. Appl. Pharmacol. 65, 180–184 (1982).
H. Poiger and C. Schlatter, Biological degradation of TCDD in rats, Nature 281, 706–707 (1979).
J. R. Olson, Metabolism and disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin in guinea pigs, Toxicol. Appl. Pharmacol. 85, 263–273 (1986).
T. A. Gasiewicz, L. E. Geider, G. Rucci, and R. A. Neal, Distribution, excretion and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J, and B6D2F1/J mice, Drug Metab. Dispos. 11(5), 397–403 (1983).
H. Poiger, H. R. Buser, H. Weber, U. Zweifel, and C. Schlatter, Structure elucidation of mammalian TCDD-metabolites, Experientia 38, 484–486 (1982).
J. M. Kleeman, J. R. Olson, and R. E. Peterson, Species differences in 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and biotransformation in fish, Fundam. Appl. Toxicol. 10, 206–213 (1988).
J. M. Wendling and R. G. Orth, Determination of [3H]-2,3,7,8-tetrachlorodibenzo-p-dioxin in human feces to ascertain its relative metabolism in man, Anal. Chem. 62, 796–800 (1990).
T. Sawahata, J. R. Olson, and R. A. Neal, Identification of metabolites of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) formed on incubation with isolated rat hepatocytes, Biochem. Biophys. Res. Commun. 105(1), 341–346 (1982).
H. Poiger and H. R. Buser, The metabolism of TCDD in the dog and rat, in: Biological Mechanisms of Dioxin Action (A. Poland and R. D. Kimbrough, eds.), pp. 39–47, Banbury Report 18, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1984).
H. Weber, H. Poiger, and C. Schlatter, Acute oral toxicity of TCDD-metabolites in male guinea pigs, Toxicol. Lett. 14, 117–122 (1982).
G. Mason and S. Safe, Synthesis, biologic and toxic effects of the major 2,3,7,8-tetrachlorodibenzo-p-dioxin metabolites in the rat, Toxicology 41, 153–159 (1986).
A. Poland and E. Glover, An estimate of the maximum in vivo covalent binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to rat liver protein, ribosomal RNA and DNA, Cancer Res. 39(9), 3341–3344 (1979).
M. K. McKinley, L. B. Kedderis, and L. S. Birnbaum, The effect of pretreatment on the biliary excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 3,3′,4,4′-tetrachlorobiphenyl in the rat, Fund. Appl. Toxicol. 21, 425–432 (1993).
V. J. Wroblewski and J. R. Olson, Effect of monooxygenase inducers and inhibitors on the hepatic metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat and hamster, Drug Metab. Dispos. 16(1), 43–51 (1988).
V. J. Wroblewski and J. R. Olson, Hepatic metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the rat and guinea pig, Toxicol. Appl. Pharmacol. 81, 231–240 (1985).
J. R. Olson, B. P. McGarrigle, P. J. Gigliotti, S. Kumar, and J. H. McReynolds, Hepatic uptake and metabolism of 2,3,7,8-TCDD and 2,3,7,8-TCDF, Fund. Appl. Toxicol. 22, 631–640 (1994).
H. L. Tai, J. H. McReynolds, J. A. Goldstein, H. P. Eugster, C. Sengstag, W. L. Alworth, and J. R. Olson, Cytochrome P-4501A1 mediates the metabolism of 2,3,7,8-tetrachlorodi-benzofuran (TCDF) in the rat and human, Toxicol. Appl. Pharmacol. 123, 34–42 (1993).
J. R. Olson, M. A. Holscher, and R. A. Neal, Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the golden Syrian hamster, Toxicol. Appl. Pharmacol. 55, 67–78 (1980).
J. L. Pirkle, W. H. Wolfe, D. G. Patterson, et al., Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Vietnam veterans of Operation Ranch Hand, J. Toxicol. Environ. Health 27, 165–171 (1989).
J. J. Ryan and Y. Masuda, Elimination of polychlorinated dibenzofurans (PCDFs) in humans from the Usho and Ucheng rice oil poisonings, in: Proc. 11th Int. Symp. on Chlorinated Dioxins and Related Compounds, Dioxin ′91, September 23–27, 1991, Research Triangle Park, NC p. 70 (1991).
A. Schecter, J. J. Ryan, and P. J. Kostyniak, Decrease over a six year period of dioxin and dibenzofuran tissue levels in a single patient following exposure, Chemosphere 20(7–9), 911–917(1990).
J. J. Ryan and Y. Masuda, Half-lives for elimination of polychlorinated dibenzofurans (PCDFs) and PCBs in humans from the Yusho and Yucheng rice oil poisonings, in: Proc. 9th Int. Symp. on Chlorinated Dioxins and Related Compounds, Dioxin ′89, September 17–22, 1989, Toronto, p. 70 (1991).
A. Schecter and T. Gasiewicz, Health hazard assessment of chlorinated dioxins and dibenzofurans contained in human milk, Chemosphere 16, 2147 (1987).
A. Schecter and T. Gasiewicz, Human breast milk levels of dioxins and dibenzofurans and their significance with respect to current risk assessments, in: Solving Hazardous Waste Problems: Learning from Dioxins, No. 191 (J. H. Exner, ed.), p. 162, American Chemical Society, Washington, DC (1987).
M. Graham, F. D. Hileman, R. G. Orth, J. M. Wendling, and J. W. Wilson, Chlorocarbons in adipose tissue from Missouri population, Chemosphere 15, 1595–1600 (1986).
A. A. Jensen, Polychlorobiphenyls (PCBs), polychlorodibenzo-p-dioxin (PCDDs) and polychlorodibenzofurans (PPPCDFs) in human milk, blood and adipose tissue, Sci. Total Environ. 64, 259–293 (1987).
C. Rappe, Analysis of polychlorinated dioxins and furans: All 75 PCDDs and 135 PPPCDFs can be identified by isomer-specific techniques, Environ. Sci. Technol. 18(3), 78A–90A (1984).
C. Rappe, M. Nyhgren, S. Marklund, et al., Assessment of human exposure to polychlorinated dibenzofurans and dioxins, Environ. Health Perspect. 60, 303–304 (1985).
P. Furst, H.-A. Meemken, and W. Groebel, Determination of polychlorinated di-benzodioxins and dibenzofurans in human milk, Chemosphere 15, 1977–1980 (1986).
M. Nygren, C. Rappe, G. Linstrom, et al., Identification of 2,3,7,8-substituted polychlorinated dioxins and dibenzofurans in environmental and human samples, in: Chlorinated Dioxins and Dibenzofurans in Perspective (C. Rappe, G. Choudhary, and L. H. Keith, eds.), pp. 17–34, Lewis Publishers, Chelsea, MI (1986).
G. Reggiani, Acute human exposure to TCDD in Sevesco, Italy, J. Toxicol. Environ. Health 6(1), 27–43 (1980).
A. Schecter, J. J. Ryan, and J. D. Constable, Chlorinated dibenzo-p-dioxin and di-benzofuran levels in human adipose tissue and milk samples from the north and south of Vietnam, Chemosphere 15, 1613 (1986).
R. W. Baughman, Tetrachlorodibenzo-p-dioxins in the environment. High resolution mass spectrometry at the picogram level, Harvard University, NTIS PB75-22939 (1975).
A. Schecter, P. Furst, J. J. Ryan, C. Furst, H.-A. Meemken, W. Grobel, J. Constable, and D. Vu, Polychlorinated dioxin and dibenzofuran levels from human milk from several locations in the United States, Germany and Vietnam, Chemosphere 19, 979 (1989).
H.-W. Leung, R. H. Ku, D. J. Paustenbach, and M. E. Andersen, A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice, Toxicol. Lett. 42, 15–28 (1988).
H.-W. Leung, D. J. Paustenbach, F. J. Murray, and M. E. Andersen, A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat, Toxicol. Appl. Pharmacol. 103, 399–410 (1990).
J. C. Kissel and G. M. Robarge, Assessing the elimination of 2,3,7,8-TCDD from humans with a physiologically based pharmacokinetic model, Chemosphere 17(10), 2017–2027 (1988).
R. J. Scheuplein, S. E. Shoaf, and R. N. Brown, Role of pharmacokinetics in safety evaluation and regulatory considerations, Annu. Rev. Pharmacol. Toxicol. 30, 197–218 (1990).
M. E. Andersen, J. J. Mills, M. L. Gargas, et al., Modeling receptor-mediated processes with dioxin: Implications for pharmacokinetics and risk assessment, Risk Anal. 13, 25–36 (1992).
R. Krowke, I. Chahoud, I. Baumann-Wilschke, and D. Neubert, Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 2. Pharmacokinetics in rats using a loading-dose/maintenance-dose regime with high doses, Arch. Toxicol. 63, 356–360 (1989).
M. C. Kohn, G. W. Lucier, G. W. Clark, G. C. Sewall, A. M. Tritscher, and C. J. Portier, A mechanistic model of effects of dioxin on gene expression in the rat liver, Toxicol. Appl. Pharmacol. 120, 138–154 (1993).
C. Schlatter,. Data on kinetics of PCDDs and PCDFs as a prerequisite for human risk assessment, in: Biological Basis for Risk Assessment of Dioxins and Related Compounds (M. A. Gallo, R. J. Scheuplein, and K. A. van der Heijnen, eds.), pp. 215–226, Banbury Report 35, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1991).
J. J. Ryan, R. Lizotte, and D. Lewis, Human tissue levels of PCDDs and PPPCDFs from a fatal pentachlorophenol poisoning, Chemosphere 16(8–9), 1989–1996 (1987).
C. C. Travis and H. A. Hattemer-Frey, Human exposure to 2,3,7,8-TCDD, Chemosphere 16(10/12), 2331–2342(1987).
H. Weber and L. S. Birnbaum, 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and 2,3,7,8-tetrachlorodibenzofuran (TCDF) in pregnant C57BL/6N mice: Distribution to the embryo and excretion, Arch. Toxicol. 57, 157–162 (1985).
H. Nau, R. Bab, and D. Neubert, Transfer of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) via placenta and milk, and postnatal toxicity in the mouse, Arch. Toxicol. 59, 36–40 (1986).
M. Vanden Berg, C. Heeremans, E. Veenhoven, and K. Olie, Transfer of polychlorinated dibenzo-p-dioxins and dibenzofurans to fetal and neonatal rats, Fundam. Appl. Toxicol. 9, 635–644 (1987).
H. Hagenmaier, T. Wiesmuller, G. Golor, R. Krowke, H. Helge, and D. Neubert, Transfer of various polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs and PCDFs) via placenta and through milk in a marmoset monkey, Arch. Toxicol. 64, 601–615 (1990).
R. E. Bowman, H. Y. Tong, M. L. Gross, S. J. Monson, and N. C. A. Weerasinghe, Controlled exposure of female rhesus monkeys to 2,3,7,8-TCDD: Concentrations of TCDD in fat of offspring, and its decline over time, Chemosphere 20(7–9), 1199–1202 (1990).
P. Furst, C. Kruger, H.-A. Meemken, and W. Groebel, PPCDD and PPCDF levels in human milk-dependence on the period of lactation, Chemosphere 18(1–6), 439–444 (1989).
T. Gorski, L. Konopka, and M. Brodzki, Persistence of some polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans of pentachlorophenol in human adipose tissue, Roczn. Pzh. T 35(4), 297–301 (1984).
W. H. Wolfe, J. E. Michalek, J. C. Miner, J. L. Pirkle, S. P. Caudill, D. G. Patterson; and L. L. Needham, Determinants of TCDD half-life in veterans of Operation Ranch Hand, J. Toxicol. Environ. Health 41, 481–488 (1994).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Olson, J.R. (1994). Pharmacokinetics of Dioxins and Related Chemicals. In: Schecter, A. (eds) Dioxins and Health. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1462-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1462-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1464-4
Online ISBN: 978-1-4899-1462-0
eBook Packages: Springer Book Archive